机构:[1]Department of Radiation Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China,[2]Cancer Center, Union Hospital, Tongji MedicalCollege, Huazhong University of Science and Technology, Wuhan, China,华中科技大学同济医学院附属协和医院[3]Department of Radiation Oncology, The General Hospital of Chinese People's Liberation Army, Beijing, China,[4]Department of Radiation Oncology,Beijing Hospital, Ministry of health, Beijing, China,[5]The Affiliated Provincial Hospital of Anhui Medical University, Hefei, China,[6]Department ofRadiation Oncology, Fujian Medical University Union Hospital, Fuzhou,China,[7]Peking Union Medical College Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing,China,[8]Department of Radiation Oncology, the Fourth Hospital of HebeiMedical University, Shijiazhuang, China,[9]Jiang Xi Province Cancer Hospital, Nanchang, China,[10]Zhejiang Cancer Hospital, Hangzhou, China,浙江省肿瘤医院[11]Department of Radiation Oncology, Fujian Provincial Cancer Hospital,Fuzhou, China,[12]Department of Lymphoma, Affiliated Hospital of GuizhouMedical University, Guizhou Cancer Hospital, Guiyang, China,[13]Department of Radiation Oncology, Hunan Cancer Hospital and the AffiliatedCancer Hospital of Xiangya School of Medicine, Changsha, China,[14]Department of Radiation Oncology, Xijing Hospital, Air Force Medical University,Xi'an, China,[15]Tianjin Medical University Cancer Institute & Hospital, KeyLaboratory of Cancer Prevention and Therapy, National Clinical ResearchCenter for Cancer, Tianjin, China,[16]Department of Radiation Oncology,Cancer Hospital and Institute, Chinese Academy of Medical Sciences(CAMS) and Peking Union Medical College (PUMC), Beijing, China,[17]Department of Oncology, 307 Hospital, Academy of Military Medical Science, Beijing, P. R. China, Beijing, China,[18]Peking University Cancer Hospital & Institute, Beijing, China,[19]Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative InnovationCenter of Cancer Medicine, Guangzhou, China,[20]Department of RadiationCenter, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China,[21]Affiliated Hospitalof Qinghai University, Xining, China,[22]Department of Radiation Oncology,Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing,China,[23]Department of Radiotherapy and Oncology, The Second AffiliatedHospital of Soochow University, SuZhou, China
出处:
ISSN:
语种:
外文
WOS:
中科院分区:
出版当年[2022]版:
大类|1 区医学
小类|2 区核医学2 区肿瘤学
最新[2025]版:
大类|1 区医学
小类|2 区肿瘤学2 区核医学
JCR分区:
出版当年[2022]版:
Q1ONCOLOGYQ1RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
最新[2024]版:
Q1ONCOLOGYQ1RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
第一作者机构:[1]Department of Radiation Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China,
推荐引用方式(GB/T 7714):
L. Xin,L.L. Zhang,B.L. Qu,et al.Evidence of Cure for Extranodal Nasal-Type NK/T-Cell Lymphoma with Modern Treatment[J].INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.2022,114(3):E349-E349.
APA:
L. Xin,L.L. Zhang,B.L. Qu,Q. Zhong,L.T. Qian...&Y.X. Li.(2022).Evidence of Cure for Extranodal Nasal-Type NK/T-Cell Lymphoma with Modern Treatment.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,114,(3)
MLA:
L. Xin,et al."Evidence of Cure for Extranodal Nasal-Type NK/T-Cell Lymphoma with Modern Treatment".INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 114..3(2022):E349-E349